Market Overview:
The global nuclear cardiology market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising geriatric population, and technological advancements in nuclear cardiology devices. The radiography devices segment is further sub-segmented into single-photon emission computed tomography (SPECT) systems and positron emission tomography/computed tomography (PET/CT) systems. The RIS segment is further sub-segmented into integrated RIS and standalone RIS. Based on application, the global nuclear cardiology market is divided into hospitals, clinics, academic and research institutes, and others segments. Geographically, the global nuclear cardiology market has been classified into North America,, Latin America,, Europe,, Asia Pacific,, Middle East & Africa regions with a detailed analysis for each region.
Product Definition:
Nuclear cardiology is a medical specialty that uses radioactive substances to image the heart. This allows physicians to see how well the heart is functioning and can help them diagnose and treat heart conditions. Nuclear cardiology is important because it can help identify problems with the heart before they become serious.
Radiology Devices:
The global nuclear cardiology devices market size was valued at USD 2.5 billion in 2015 and is expected to grow at a CAGR of XX% during the forecast period. The key drivers attributing to its rapid growth include rising prevalence of cardiovascular diseases, increasing geriatric population prone to cardiac disorders, and growing demand for non-invasive diagnostic procedures.
Radiology Information Systems (RIS):
The radiology information systems (RIS) is a software system that helps in storing, organizing, and retrieving medical imaging data. It also helps in reducing the time taken for diagnosis of any disease by providing relevant information to radiologists.
Application Insights:
The market is segmented by application into hospitals, clinics, academic and research institutes, and others. The hospitals segment dominated the global nuclear cardiology market in 2017 owing to factors such as increasing prevalence of cardiac diseases and rising geriatric population at hospitals. Moreover, presence of key players with experience in R&D for developing advanced products for cardiac imaging is also expected to drive the growth over the forecast period.
The clinics segment is expected to grow significantly during the forecast period due to growing adoption of nuclear medicine imaging devices by physicians across North America and Europe regions. For instance, Cardio Diagnostics Ltd., a company involved in development & manufacturing of innovative diagnostic solutions for heart diseases has introduced newgeneration gamma camera that provides better image quality than conventional cameras enabling accurate diagnosis even at a late stage when treatment becomes difficult or impossible due to extensive damage done by disease process.
Regional Analysis:
North America dominated the global nuclear cardiology market in 2016. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and favorable government initiatives are some factors responsible for its large share. For instance, the American College of Nuclear Medicine (ACNM) was established to provide education and certification for medical professionals who work with radioactive material in diagnosis or treatment procedures.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing awareness about nuclear cardiology among physicians and patients as well as rising demand for technologically advanced products that can be used during an emergency situation. Moreover, economic development coupled with improving healthcare facilities is also anticipated to boost growth over this period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) across the globe is expected to drive the demand for nuclear cardiology over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to CVDs.
- Rising awareness about early diagnosis and treatment of heart diseases through nuclear cardiology procedures will propel the market growth in coming years.
- Technological advancements in nuclear cardiology equipment and increasing number of private diagnostic centers are some other factors that are expected to fuel the market growth during forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Nuclear Cardiology Market Research Report
By Type
Radiology Devices, Radiology Information Systems (RIS), Radiopharmaceuticals
By Application
Hospitals, Clinics, Academic and Research Institutes, Others
By Companies
GE Healthcare, Shimadzu, Siemens Healthcare, Fujifilm Medical, Astellas Pharma, Philips Healthcare, Medtronic, mensio Medical Imaging, Bracco Diagnostics, UltraSPECT
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Nuclear Cardiology Market Report Segments:
The global Nuclear Cardiology market is segmented on the basis of:
Types
Radiology Devices, Radiology Information Systems (RIS), Radiopharmaceuticals
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Shimadzu
- Siemens Healthcare
- Fujifilm Medical
- Astellas Pharma
- Philips Healthcare
- Medtronic
- mensio Medical Imaging
- Bracco Diagnostics
- UltraSPECT
Highlights of The Nuclear Cardiology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiology Devices
- Radiology Information Systems (RIS)
- Radiopharmaceuticals
- By Application:
- Hospitals
- Clinics
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nuclear Cardiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nuclear cardiology is the study of heart disease and its effects on the heart's nuclear cells.
Some of the major companies in the nuclear cardiology market are GE Healthcare, Shimadzu, Siemens Healthcare, Fujifilm Medical, Astellas Pharma, Philips Healthcare, Medtronic, mensio Medical Imaging, Bracco Diagnostics, UltraSPECT.
The nuclear cardiology market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nuclear Cardiology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nuclear Cardiology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nuclear Cardiology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nuclear Cardiology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nuclear Cardiology Market Size & Forecast, 2020-2028
4.5.1 Nuclear Cardiology Market Size and Y-o-Y Growth
4.5.2 Nuclear Cardiology Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Radiology Devices
5.2.2 Radiology Information Systems (RIS)
5.2.3 Radiopharmaceuticals
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Academic and Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nuclear Cardiology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nuclear Cardiology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Radiology Devices
9.6.2 Radiology Information Systems (RIS)
9.6.3 Radiopharmaceuticals
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Academic and Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Radiology Devices
10.6.2 Radiology Information Systems (RIS)
10.6.3 Radiopharmaceuticals
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Academic and Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Radiology Devices
11.6.2 Radiology Information Systems (RIS)
11.6.3 Radiopharmaceuticals
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Academic and Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Radiology Devices
12.6.2 Radiology Information Systems (RIS)
12.6.3 Radiopharmaceuticals
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Academic and Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Radiology Devices
13.6.2 Radiology Information Systems (RIS)
13.6.3 Radiopharmaceuticals
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Academic and Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nuclear Cardiology Market: Competitive Dashboard
14.2 Global Nuclear Cardiology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Shimadzu
14.3.3 Siemens Healthcare
14.3.4 Fujifilm Medical
14.3.5 Astellas Pharma
14.3.6 Philips Healthcare
14.3.7 Medtronic
14.3.8 mensio Medical Imaging
14.3.9 Bracco Diagnostics
14.3.10 UltraSPECT
